JP2019211473A - 未知の分子種の標識化状態を検出するための方法 - Google Patents
未知の分子種の標識化状態を検出するための方法 Download PDFInfo
- Publication number
- JP2019211473A JP2019211473A JP2019100179A JP2019100179A JP2019211473A JP 2019211473 A JP2019211473 A JP 2019211473A JP 2019100179 A JP2019100179 A JP 2019100179A JP 2019100179 A JP2019100179 A JP 2019100179A JP 2019211473 A JP2019211473 A JP 2019211473A
- Authority
- JP
- Japan
- Prior art keywords
- sample
- isotope
- molecular species
- mass
- labeling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 211
- 238000002372 labelling Methods 0.000 title claims abstract description 115
- 239000000523 sample Substances 0.000 claims abstract description 175
- 230000008569 process Effects 0.000 claims abstract description 134
- 238000001819 mass spectrum Methods 0.000 claims abstract description 95
- 239000000203 mixture Substances 0.000 claims abstract description 90
- 239000013074 reference sample Substances 0.000 claims abstract description 66
- 238000001948 isotopic labelling Methods 0.000 claims abstract description 43
- 238000004949 mass spectrometry Methods 0.000 claims abstract description 5
- 230000000155 isotopic effect Effects 0.000 claims description 30
- 238000001514 detection method Methods 0.000 claims description 7
- 238000004458 analytical method Methods 0.000 claims description 4
- 230000004907 flux Effects 0.000 claims description 4
- 241000894007 species Species 0.000 description 139
- 230000000875 corresponding effect Effects 0.000 description 32
- 125000004429 atom Chemical group 0.000 description 29
- 150000002500 ions Chemical class 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 14
- 238000005259 measurement Methods 0.000 description 14
- 239000003550 marker Substances 0.000 description 13
- 238000004811 liquid chromatography Methods 0.000 description 12
- 238000010828 elution Methods 0.000 description 10
- 238000004581 coalescence Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 238000013459 approach Methods 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- 230000036962 time dependent Effects 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000000977 initiatory effect Effects 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000012854 evaluation process Methods 0.000 description 2
- 238000005040 ion trap Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01J—ELECTRIC DISCHARGE TUBES OR DISCHARGE LAMPS
- H01J49/00—Particle spectrometers or separator tubes
- H01J49/0027—Methods for using particle spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2458/00—Labels used in chemical analysis of biological material
- G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Electrochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
cM(0)+cM(1)+cM(2)+…+cM(k−1)+cM(k)=1
Claims (6)
- 質量分析を使用して、不変同位体標識化プロセスに曝露された試料中に含まれる未知の分子種Mの標識化状態を検出するための方法であって、
− 質量分析計を用いて、前記不変同位体標識化プロセスに曝露されていない、または前記不変同位体標識化プロセスの開始時に前記プロセスに曝露されているのみである参照試料の少なくとも1つの質量スペクトルIul(pul)を測定することと、
− 前記不変同位体標識化プロセスにおいて前記試料を標識化することと、
− 前記不変同位体標識化プロセスの開始後に、質量分析計を用いて前記試料の質量スペクトルIl(pl)を測定することと、
− 前記参照試料の前記少なくとも1つの測定質量スペクトルIul(pul)に基づいて、参照試料に含まれる少なくとも1つの未知の分子種Mの1つ以上の最も可能性の高い元素組成CM,i(+0)を決定することと、
− 前記参照試料に含まれる少なくとも1つの未知の分子種Mのそれぞれの決定された1つ以上の最も可能性の高い元素組成CM,i(+0)について、前記試料の前記測定質量スペクトルIl(pl)において、前記試料に含まれる対応する分子種Mlを、前記参照試料に含まれる少なくとも1つの未知の分子種Mのそれぞれの特定された1つ以上の最も可能性の高い元素組成CM,i(+0)について、
前記元素組成CM,i(+0)、および前記元素組成CM,i(+0)の少なくとも1つの別個の標識化状態CM,i(+n1,+n2,...,+nw)について、同位体ピークパターンIM(+u),iを決定するステップと、
前記元素組成CM,i(+0)について、前記元素組成CM,i(+0)の同位体ピークパターンIM(+u1,+u2,…,+uw),i、および前記元素組成CM,i(+0)の前記少なくとも1つの別個の標識化状態CM,i(+n1,+n2,...,+nw)を使用して、前記対応する分子種Mlの検出可能な質量mMl,mを決定するステップと、
前記元素組成CM,i(+0)について、前記対応する分子種Mlの前記決定された検出可能な質量mMl,mにおける前記試料の少なくとも1つの測定質量スペクトルIl(pl)から、前記対応する分子種Mlの同位体ピークパターンIMl,mを決定するステップとを使用して検出することと、
− 前記参照試料に含まれる少なくとも1つの未知の分子種Mのそれぞれの特定された1つ以上の最も可能性の高い元素組成について、
前記対応する分子種Mlのそれぞれの決定された検出可能な質量mMl,mについて、前記対応する分子種Mlの前記決定された同位体ピークパターンIMl,mにおいての前記決定された検出可能な質量mMl,kにおけるピーク強度を、前記同位体ピークパターンIM(+u1,+u2,…,+uw),iが決定された前記元素組成CM,i(+0)および別個の標識化状態CM,i(+n1,+n2,...,+nw)の同位体ピークパターンIM(+u1,+u2,…,+uw),iにおける前記決定された検出可能な質量mMl,mのピーク強度と比較することにより、前記元素組成CM,i(+0)について、前記同位体ピークパターンIM(+u1,+u2,…,+uw),iが決定された前記元素組成CM,i(+0)の非標識化状態および前記別個の標識化状態CM,i(+n1,+n2,...,+nw)の強度寄与LM,i(n1,n2,...,nw)を決定することによって、前記試料の前記測定質量スペクトルIl(pl)から前記試料中の前記対応する分子種Mlの標識化状態を決定することと
を含む方法。 - 前記不変同位体標識化プロセスの開始後の期間中に、前記試料の質量スペクトルIl(pl)が測定され、この期間中に、参照試料に含まれる少なくとも1つの分子種Mのそれぞれの特定された1つ以上の最も可能性の高い元素組成について、前記試料中の前記未知の分子種Mの標識化状態が、前記試料の前記測定された質量スペクトルIl(pl)から決定される、請求項1に記載の方法。
- すべての可能性のある別個の標識化状態について、前記同位体ピークパターンが決定され、前記方法の後続のステップにおいて使用される、請求項1または2に記載の方法。
- 前記参照試料に含まれる少なくとも1つの未知の分子種Mのそれぞれの特定された1つ以上の最も可能性の高い元素組成について、前記試料中の前記対応する分子種Mlの標識化状態が、前記対応する分子種Mlのそれぞれの決定された検出可能な質量mMl,mについて、前記元素組成CM,i(+0)の前記非標識化状態および前記別個の標識化状態CM,i(+n1,+n2,...,+nw)の強度寄与LM,i(n1,n2,...,nw)と、前記同位体ピークパターンIM(+u1,+u2,…,+uw),iが決定された前記元素組成CM,i(+0)および前記別個の標識化状態CM,i(+n1,+n2,...,+nw)の前記同位体ピークパターンIM(+u1,+u2,…,+uw),iにおける前記予測される検出可能な質量mMl,mにおけるピーク強度との線形結合を、前記同位体ピークパターンIM(+u1,+u2,…,+uw),iが決定された前記元素組成CM,i(+0)および前記別個の標識化状態CM,i(+n1,+n2,...,+nw)の前記同位体ピークパターンIM(+u1,+u2,…,+uw),iにおける前記決定された検出可能な質量mMl,mのピーク強度と比較することにより、前記試料の前記測定質量スペクトルIl(pl)から決定される、請求項1〜3の少なくとも一項に記載の方法。
- 前記試料が、不変単一濃縮同位体標識化プロセスによって標識化される、請求項1〜4の少なくとも一項に記載の方法。
- 請求項1〜5のいずれか一項に記載の試料中に含まれる未知の分子種Mの標識化状態を検出するための方法を使用するフラックス分析の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18175630.5A EP3576129B1 (en) | 2018-06-01 | 2018-06-01 | Method for detecting the isotopic labelling state of unknown species of molecules |
EP18175630.5 | 2018-06-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019211473A true JP2019211473A (ja) | 2019-12-12 |
JP6896794B2 JP6896794B2 (ja) | 2021-06-30 |
Family
ID=62567282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019100179A Active JP6896794B2 (ja) | 2018-06-01 | 2019-05-29 | 未知の分子種の標識化状態を検出するための方法 |
Country Status (4)
Country | Link |
---|---|
US (1) | US11105781B2 (ja) |
EP (1) | EP3576129B1 (ja) |
JP (1) | JP6896794B2 (ja) |
CN (1) | CN110554082B (ja) |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL57570A (en) * | 1978-06-22 | 1982-07-30 | Miles Lab | Method and reagent for specific binding assay with a prosthetic group as a label component |
FR2673291A1 (fr) * | 1991-02-27 | 1992-08-28 | Inbiomed International | Procede d'authentification de l'origine d'un produit constitue d'un melange de composes organiques par marquage isotopique. |
DE19803309C1 (de) * | 1998-01-29 | 1999-10-07 | Bruker Daltonik Gmbh | Massenspektrometrisches Verfahren zur genauen Massenbestimmung unbekannter Ionen |
SE0000754D0 (sv) * | 2000-03-07 | 2000-03-07 | Amersham Pharm Biotech Ab | Mass spectral peak identification |
US7632686B2 (en) * | 2002-10-03 | 2009-12-15 | Anderson Forschung Group | High sensitivity quantitation of peptides by mass spectrometry |
US20070158542A1 (en) * | 2003-05-15 | 2007-07-12 | Electrophoretics Limited | Mass spectrometry |
GB2404194A (en) * | 2003-07-21 | 2005-01-26 | Amersham Biosciences Ab | Automated chromatography/mass spectrometry analysis |
US10755905B2 (en) * | 2004-10-28 | 2020-08-25 | Cerno Bioscience Llc | Qualitative and quantitative mass spectral analysis |
DK2108111T3 (da) * | 2006-12-07 | 2019-07-15 | Definitek Inc | Fastfase- og katalyseaktiveret automatiseret isotopfortynding og specieret isotopfortyndingsmassespektrometri |
WO2008146100A1 (en) * | 2007-06-01 | 2008-12-04 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Method for absolute quantification of polypeptides |
CN103163226A (zh) * | 2011-12-14 | 2013-06-19 | 刘丽宏 | 30种氨基酸同时定量检测方法及试剂盒制备 |
TWI484037B (zh) * | 2012-05-07 | 2015-05-11 | Nat Univ Chung Cheng | 乙基化胸腺嘧啶dna加成產物之偵測方法 |
CN103134881A (zh) * | 2013-02-01 | 2013-06-05 | 浙江省疾病预防控制中心 | 一种牛α-乳白蛋白定量检测试剂盒及其应用 |
KR101497799B1 (ko) * | 2013-04-08 | 2015-03-04 | 창원대학교 산학협력단 | 새로운 질량값을 갖는 동위원소 표지된 n-연결형 글리칸과 이의 제조방법, 및 동위원소 표지된 n-연결형 글리칸의 비교정량 질량분석방법 |
GB2514836B (en) * | 2013-06-07 | 2020-04-22 | Thermo Fisher Scient Bremen Gmbh | Isotopic Pattern Recognition |
US20180259531A1 (en) * | 2015-09-08 | 2018-09-13 | Kinemed, Inc. | Measurement of molecular flux rates by quantifying isotopologue abundances using high resolution mass spectrometry |
KR101766129B1 (ko) * | 2016-03-17 | 2017-08-07 | 창원대학교 산학협력단 | 대사작용에 의한 13c 동위원소가 표지된 글리칸과 이의 제조방법 및 동위원소 표지된 글리칸의 비교정량 질량분석방법 |
EP3293754A1 (en) * | 2016-09-09 | 2018-03-14 | Thermo Fisher Scientific (Bremen) GmbH | Method for identification of the monoisotopic mass of species of molecules |
US10615015B2 (en) * | 2017-02-23 | 2020-04-07 | Thermo Fisher Scientific (Bremen) Gmbh | Method for identification of the elemental composition of species of molecules |
EP3410109A1 (en) * | 2017-06-02 | 2018-12-05 | Thermo Fisher Scientific (Bremen) GmbH | Systems and methods for extracting mass traces |
-
2018
- 2018-06-01 EP EP18175630.5A patent/EP3576129B1/en active Active
-
2019
- 2019-05-24 CN CN201910439832.6A patent/CN110554082B/zh active Active
- 2019-05-29 US US16/425,013 patent/US11105781B2/en active Active
- 2019-05-29 JP JP2019100179A patent/JP6896794B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP6896794B2 (ja) | 2021-06-30 |
CN110554082A (zh) | 2019-12-10 |
EP3576129A1 (en) | 2019-12-04 |
US20190369067A1 (en) | 2019-12-05 |
EP3576129B1 (en) | 2023-05-03 |
US11105781B2 (en) | 2021-08-31 |
CN110554082B (zh) | 2022-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Danzi et al. | To metabolomics and beyond: a technological portfolio to investigate cancer metabolism | |
Moldoveanu et al. | Selection of the HPLC method in chemical analysis | |
Rathahao-Paris et al. | High resolution mass spectrometry for structural identification of metabolites in metabolomics | |
Theodoridis et al. | Mass spectrometry‐based holistic analytical approaches for metabolite profiling in systems biology studies | |
Yin et al. | Current state-of-the-art of nontargeted metabolomics based on liquid chromatography–mass spectrometry with special emphasis in clinical applications | |
Ojanperä et al. | Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time‐of‐flight mass spectrometry | |
JP4818116B2 (ja) | メタボノミクスにおいてlc−msまたはlc−ms/msデータの処理を行うための方法およびデバイス | |
Metz et al. | Future of liquid chromatography–mass spectrometry in metabolic profiling and metabolomic studies for biomarker discovery | |
Bonner et al. | SWATH acquisition mode for drug metabolism and metabolomics investigations | |
Kirkwood et al. | Simultaneous, untargeted metabolic profiling of polar and nonpolar metabolites by LC‐Q‐TOF mass spectrometry | |
Feuerstein et al. | Novel acquisition strategies for metabolomics using drift tube ion mobility-quadrupole resolved all ions time-of-flight mass spectrometry (IM-QRAI-TOFMS) | |
Zhang et al. | Assessing the suitability of capillary electrophoresis‐mass spectrometry for biomarker discovery in plasma‐based metabolomics | |
Roessner et al. | Metabolite measurements | |
Ju et al. | Removal of false positive features to generate authentic peak table for high-resolution mass spectrometry-based metabolomics study | |
DeBastiani et al. | Characterizing multidevice capillary vibrating sharp-edge spray ionization for in-droplet hydrogen/deuterium exchange to enhance compound identification | |
CN109526237A (zh) | 使用swath方法扩展动态范围 | |
Doucette et al. | Molecular-formula determination through accurate-mass analysis: A forensic investigation | |
US7820964B2 (en) | Method for generation and use of stable isotope patterns in mass spectral data | |
Stenson et al. | Ion molecule reaction H/D exchange as a probe for isomeric fractionation in chromatographically separated natural organic matter | |
JP6896794B2 (ja) | 未知の分子種の標識化状態を検出するための方法 | |
Rodrigues et al. | Standard key steps in mass spectrometry-based plant metabolomics experiments: Instrument performance and analytical method validation | |
Brophy et al. | Ion-neutral clustering of bile acids in electrospray ionization across UPLC flow regimes | |
Hissong et al. | Compound Identification Strategies in Mass Spectrometry-Based Metabolomics and Pharmacometabolomics | |
Hobby et al. | A new approach to aid the characterisation and identification of metabolites of a model drug; partial isotope enrichment combined with novel formula elucidation software | |
Shanthamoorthy et al. | Analyzing Assay Redundancy in Metabolomics using Unique Ion Signatures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190530 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200608 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20200907 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20201106 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201207 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210510 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210609 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6896794 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |